IONS - Ionis Pharmaceuticals, Inc.
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 5.08B |
| Enterprise Value | 4.46B |
| Trailing P/E | 114.71 |
| Forward P/E | 90.91 |
| PEG Ratio (5 yr expected) | 25.70 |
| Price/Sales (ttm) | 8.39 |
| Price/Book (mrq) | 8.67 |
| Enterprise Value/Revenue | 7.74 |
| Enterprise Value/EBITDA | -15.74 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.54 |
| 52-Week Change 3 | 22.72% |
| S&P500 52-Week Change 3 | 3.90% |
| 52 Week High 3 | 48.82 |
| 52 Week Low 3 | 32.69 |
| 50-Day Moving Average 3 | 36.88 |
| 200-Day Moving Average 3 | 40.00 |
Share Statistics
| Avg Vol (3 month) 3 | 1.01M |
| Avg Vol (10 day) 3 | 1.48M |
| Shares Outstanding 5 | 143.09M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 142.04M |
| % Held by Insiders 1 | 0.74% |
| % Held by Institutions 1 | 93.22% |
| Shares Short (May 14, 2023) 4 | 7.11M |
| Short Ratio (May 14, 2023) 4 | 8.02 |
| Short % of Float (May 14, 2023) 4 | 5.88% |
| Short % of Shares Outstanding (May 14, 2023) 4 | 4.97% |
| Shares Short (prior month Apr 13, 2023) 4 | 6.92M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Mar 30, 2023 |
Profitability
| Profit Margin | -57.10% |
| Operating Margin (ttm) | -80.70% |
Management Effectiveness
| Return on Assets (ttm) | -10.75% |
| Return on Equity (ttm) | -54.99% |
Income Statement
| Revenue (ttm) | 575.97M |
| Revenue Per Share (ttm) | 4.05 |
| Quarterly Revenue Growth (yoy) | -8.00% |
| Gross Profit (ttm) | -257.87M |
| EBITDA | -449.14M |
| Net Income Avi to Common (ttm) | -328.88M |
| Diluted EPS (ttm) | -2.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.35B |
| Total Cash Per Share (mrq) | 16.45 |
| Total Debt (mrq) | 1.36B |
| Total Debt/Equity (mrq) | 279.79 |
| Current Ratio (mrq) | 9.81 |
| Book Value Per Share (mrq) | 3.40 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -376.71M |
| Levered Free Cash Flow (ttm) | -180.15M |
© 2023 Yahoo. All rights reserved.